Larry Biegelsen
Stock Analyst at Wells Fargo
(3.60)
# 788
Out of 5,165 analysts
371
Total ratings
51.15%
Success rate
4.69%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVR Anteris Technologies Global | Initiates: Overweight | $16 | $5.97 | +168.01% | 1 | Mar 11, 2026 | |
| TFX Teleflex | Maintains: Equal-Weight | $116 → $130 | $109.00 | +19.27% | 10 | Feb 27, 2026 | |
| MMSI Merit Medical Systems | Downgrades: Equal-Weight | $95 → $78 | $70.23 | +11.06% | 13 | Feb 26, 2026 | |
| ALC Alcon | Upgrades: Overweight | $88 → $97 | $77.78 | +24.71% | 10 | Feb 26, 2026 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $17 → $18 | $16.71 | +7.72% | 10 | Feb 19, 2026 | |
| AXGN Axogen | Initiates: Overweight | $40 | $32.75 | +22.14% | 1 | Feb 19, 2026 | |
| GKOS Glaukos | Maintains: Overweight | $122 → $135 | $102.93 | +31.16% | 18 | Feb 18, 2026 | |
| DXCM DexCom | Maintains: Overweight | $93 → $85 | $67.32 | +26.26% | 11 | Feb 13, 2026 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $145 → $70 | $55.15 | +26.93% | 16 | Feb 12, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $93 → $98 | $92.52 | +5.92% | 11 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $96 → $100 | $84.27 | +18.67% | 19 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $97 | $72.34 | +34.09% | 6 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $94 | $71.20 | +32.02% | 16 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $38 | $22.52 | +68.74% | 1 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $230 → $240 | $238.11 | +0.79% | 15 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $374 | $338.00 | +10.65% | 20 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $28 | $21.14 | +32.45% | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $72 → $82 | $72.05 | +13.81% | 20 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $114 | $88.44 | +28.90% | 19 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $452 → $456 | $349.11 | +30.62% | 17 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $14 | $23.91 | -41.45% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $10 | $7.56 | +32.28% | 16 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $482.76 | +24.29% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.30 | -34.62% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $1.62 | +85.19% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $17.62 | +36.21% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $12.35 | +17.41% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $13.82 | +23.01% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $9.10 | +438.46% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $110.71 | +22.84% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $88.16 | -20.60% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $161.64 | +67.04% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $80.45 | - | 2 | Nov 2, 2017 |
Anteris Technologies Global
Mar 11, 2026
Initiates: Overweight
Price Target: $16
Current: $5.97
Upside: +168.01%
Teleflex
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $116 → $130
Current: $109.00
Upside: +19.27%
Merit Medical Systems
Feb 26, 2026
Downgrades: Equal-Weight
Price Target: $95 → $78
Current: $70.23
Upside: +11.06%
Alcon
Feb 26, 2026
Upgrades: Overweight
Price Target: $88 → $97
Current: $77.78
Upside: +24.71%
Bausch + Lomb
Feb 19, 2026
Maintains: Equal-Weight
Price Target: $17 → $18
Current: $16.71
Upside: +7.72%
Axogen
Feb 19, 2026
Initiates: Overweight
Price Target: $40
Current: $32.75
Upside: +22.14%
Glaukos
Feb 18, 2026
Maintains: Overweight
Price Target: $122 → $135
Current: $102.93
Upside: +31.16%
DexCom
Feb 13, 2026
Maintains: Overweight
Price Target: $93 → $85
Current: $67.32
Upside: +26.26%
Inspire Medical Systems
Feb 12, 2026
Downgrades: Equal-Weight
Price Target: $145 → $70
Current: $55.15
Upside: +26.93%
Zimmer Biomet Holdings
Feb 11, 2026
Maintains: Equal-Weight
Price Target: $93 → $98
Current: $92.52
Upside: +5.92%
Feb 11, 2026
Maintains: Overweight
Price Target: $96 → $100
Current: $84.27
Upside: +18.67%
Feb 5, 2026
Maintains: Overweight
Price Target: $95 → $97
Current: $72.34
Upside: +34.09%
Feb 5, 2026
Maintains: Overweight
Price Target: $125 → $94
Current: $71.20
Upside: +32.02%
Jan 28, 2026
Initiates: Overweight
Price Target: $38
Current: $22.52
Upside: +68.74%
Jan 22, 2026
Maintains: Overweight
Price Target: $230 → $240
Current: $238.11
Upside: +0.79%
Jan 15, 2026
Downgrades: Equal-Weight
Price Target: $374
Current: $338.00
Upside: +10.65%
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $28
Current: $21.14
Upside: +32.45%
Dec 5, 2025
Maintains: Equal-Weight
Price Target: $72 → $82
Current: $72.05
Upside: +13.81%
Nov 19, 2025
Maintains: Overweight
Price Target: $100 → $114
Current: $88.44
Upside: +28.90%
Nov 14, 2025
Maintains: Overweight
Price Target: $452 → $456
Current: $349.11
Upside: +30.62%
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $23.91
Upside: -41.45%
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $7.56
Upside: +32.28%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $482.76
Upside: +24.29%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.30
Upside: -34.62%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.62
Upside: +85.19%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $17.62
Upside: +36.21%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $12.35
Upside: +17.41%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $13.82
Upside: +23.01%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $9.10
Upside: +438.46%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $110.71
Upside: +22.84%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $88.16
Upside: -20.60%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $161.64
Upside: +67.04%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $80.45
Upside: -